Ventas, Inc. $VTR Shares Sold by Sarasin & Partners LLP

Sarasin & Partners LLP decreased its holdings in shares of Ventas, Inc. (NYSE:VTR) by 25.9% in the 4th quarter, Holdings Channel reports. The firm owned 26,250 shares of the real estate investment trust’s stock after selling 9,190 shares during the quarter. Sarasin & Partners LLP’s holdings in Ventas were worth $2,031,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. GoalVest Advisory LLC bought a new position in shares of Ventas in the 4th quarter worth about $26,000. Cloud Capital Management LLC bought a new stake in shares of Ventas during the 3rd quarter valued at about $25,000. Wiser Advisor Group LLC acquired a new stake in Ventas during the third quarter worth about $27,000. True Wealth Design LLC raised its stake in Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after acquiring an additional 405 shares during the period. Finally, Wilmington Savings Fund Society FSB lifted its holdings in Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock worth $32,000 after acquiring an additional 180 shares during the last quarter. 94.18% of the stock is owned by institutional investors and hedge funds.

Ventas Stock Performance

Shares of VTR stock opened at $82.46 on Friday. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $88.36. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67. The firm has a market capitalization of $39.16 billion, a price-to-earnings ratio of 152.70, a price-to-earnings-growth ratio of 2.04 and a beta of 0.73. The business has a 50 day simple moving average of $82.51 and a 200 day simple moving average of $77.03.

Ventas (NYSE:VTR) last announced its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the previous year, the firm earned $0.81 EPS. The firm’s revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, equities research analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.52 per share. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, March 31st. Ventas’s dividend payout ratio (DPR) is presently 355.56%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on Ventas from $88.00 to $93.00 and gave the company an “overweight” rating in a research report on Friday. Royal Bank Of Canada raised their target price on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research note on Tuesday, February 10th. Argus set a $88.00 price target on shares of Ventas in a report on Tuesday, February 10th. Citigroup upped their price target on shares of Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. Finally, Mizuho increased their price objective on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, March 4th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $90.13.

Insider Buying and Selling

In related news, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the transaction, the chief financial officer owned 138,434 shares in the company, valued at $10,694,026.50. This represents a 17.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the transaction, the executive vice president directly owned 72,755 shares in the company, valued at approximately $6,184,175. The trade was a 32.81% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 86,106 shares of company stock valued at $6,931,397 over the last 90 days. 0.80% of the stock is currently owned by company insiders.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.